Published in Medical Letter on the CDC and FDA, June 21st, 2006
The studies, taking place at Duke University Medical Center, Emory University and University of Texas Health Science Center, are designed to identify areas of the brain activated by acute and long-term VNS therapy and further establish the rationale for the long-term sustained responses that have been reported with VNS therapy in TRD.
The VNS Therapy Mechanism of Action Advisory Board, chaired by Charles B. Nemeroff, MD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA